Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing admin@sinochem-nanjing.com 3389378665@qq.com
Follow us:

N-Tert-Butoxycarbonyl-7-Bromoindoline

    • Product Name N-Tert-Butoxycarbonyl-7-Bromoindoline
    • Alias Boc-7-bromoindoline
    • Mininmum Order 1 g
    • Factory Site Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing
    • Price Inquiry admin@sinochem-nanjing.com
    • Manufacturer Sinochem Nanjing Corporation
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    315815

    Product Name N-Tert-Butoxycarbonyl-7-Bromoindoline
    Cas Number 1110776-99-0
    Molecular Formula C13H16BrNO2
    Molecular Weight 298.18 g/mol
    Appearance White to off-white solid
    Melting Point 89-92°C
    Purity Typically ≥ 98%
    Storage Temperature 2-8°C (Refrigerated)
    Smiles CC(C)(C)OC(=O)N1CCc2ccc(Br)cc21
    Iupac Name tert-butyl 7-bromo-2,3-dihydro-1H-indole-1-carboxylate

    As an accredited N-Tert-Butoxycarbonyl-7-Bromoindoline factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing
    Shipping
    Storage
    Application of N-Tert-Butoxycarbonyl-7-Bromoindoline

    Applications of N-Tert-Butoxycarbonyl-7-Bromoindoline in Industrial Manufacturing

    N-Tert-Butoxycarbonyl-7-Bromoindoline supports precision synthesis across several specialized chemical sectors. Its protective group functionality and brominated scaffold allow specific downstream manufacturing integration, especially in advanced pharmaceutical and fine chemical processes. Below, we detail key industrial application tracks with direct relevance to regulated production environments.

    1. Active Pharmaceutical Ingredient (API) Intermediates for CNS Drug Synthesis

    Pharmaceutical manufacturers regularly employ N-Tert-Butoxycarbonyl-7-Bromoindoline as a protected indoline intermediate in multi-step synthesis of central nervous system (CNS) APIs, especially for compounds targeting serotonin and dopamine receptor modulation. This intermediate offers a stable Boc protection on the nitrogen, streamlining selective functionalization at the brominated aryl position. Research-based and commercial processing facilities use it during early to mid-stage development for small molecule drug candidates, followed by deprotection and coupling reactions. Precise adherence to GMP processes and international pharmacopoeial standards governs its industrial use at all production scales.

    Industry compliance standards

    • ICH Q7: Good Manufacturing Practice Guideline for Active Pharmaceutical Ingredients
    • EU GMP Part II requirements
    • USP/Ph. Eur. monograph compliance (as applicable to intermediates)
    • FDA 21 CFR Part 210/211 (for US-regulated facilities)

    Typical usage ratio

    • Used at 0.8–1.2 equivalents relative to the core starting material in coupling reactions. Adjustment depends on process yield optimization and minimization of excess protecting agent.

    Downstream process integration

    • Enters synthesis during N-protection and bromination stages.
    • Integration prior to subsequent cross-coupling or reductive amination steps.
    • Boc deprotection performed after finished indoline core assembly.
    • Final purification by crystallization or preparative chromatography prior to API synthesis continuation.

    Final product types

    • Developed CNS active pharmaceutical ingredients
    • Clinical trial batch APIs
    • Scale-up intermediates for commercial drugs
    • Custom research compounds for neuropharmacology

    2. Fine Chemical Synthesis of Indoline-Based Pigment Intermediates

    Colorant and fine chemical manufacturers utilize this indoline derivative as a building block in the production of high-value specialty pigments, including indoline yellow and related azo coupling products. The bromine at the 7-position facilitates regioselective substitution or cross-coupling, while the Boc group enables staged synthesis and process control by protecting the indoline nitrogen until desired deprotection. Facilities require strict contaminant monitoring and batch-to-batch color uniformity, with careful control of all intermediates’ purity profiles.

    Industry compliance standards

    • EN 71-3:2019 (for pigments applied in toys and children's goods)
    • ISO 9001:2015 Quality Management System
    • REACH regulation EC No. 1907/2006 (for EU market)
    • ASTM D6766-20 guidelines for pigment chemistry

    Typical usage ratio

    • Ranges from 10–20% of total batch mass, depending on pigment intensity requirements and intermediate yield in azo/condensation steps.

    Downstream process integration

    • Enters initial pigment intermediate synthesis via protected indoline preparation.
    • Subsequent palladium-catalyzed cross-coupling to introduce additional substituents.
    • Boc deprotection before final condensation with chromophores.
    • Drying, milling, and blending post-synthesis as required for finished pigment formulation.

    Final product types

    • Indoline-based organic pigments
    • Azo pigment intermediates
    • High-purity colorants for inks and coatings
    • Pigment additives for plastics and specialty paints

    3. Custom Peptide Synthesis Protecting Group Chemistry

    In high-throughput peptide synthesis labs, operators select N-Tert-Butoxycarbonyl-7-Bromoindoline to protect the indoline nitrogen moiety in rare non-standard amino acid analogues or constrained peptide backbones. The Boc group offers robust protection under standard Fmoc solid-phase synthesis conditions. The brominated indoline unit supports tailored structural modifications, critical for bioactive peptide research. Application is prevalent in the synthesis of analogues for drug discovery, molecular probes, and biomarker studies, subject to biocompatibility and trace-level impurity controls.

    Industry compliance standards

    • GMP regulation for starting materials in peptide drug production (as per EMA/CHMP/QWP/545525/2017)
    • IPEC-PQG GMP Guide for Pharmaceutical Excipients
    • USP General Chapter <1047> (for peptide synthesis)
    • ISO 13485:2016 (for peptides used in diagnostic kits)

    Typical usage ratio

    • Typically 1:1 molar base equivalence with resin-bound amino group, adjusted to 1.1 equivalents to achieve complete reaction and minimize double additions.

    Downstream process integration

    • Initial attachment as a protected unit in nonstandard residue incorporation.
    • Analog synthesis via automated or manual peptide synthesizers after resin loading.
    • Boc group removal handled under acidolytic cleavage post-assembly.
    • Final product isolation via preparative HPLC and lyophilization.

    Final product types

    • Peptide drug candidates containing modified indoline motifs
    • Molecular probe peptides for biomedical research
    • Specialty peptides for diagnostic assay kits
    • Noncanonical amino acid libraries for screening

    4. Chemical Probe and Bioactive Scaffold Development

    Research and contract manufacturing organizations deploy the compound as a scaffold for chemical probe design, specifically in the creation of targeted bioactive molecules for in vitro and in vivo target validation. The bromine atom enables late-stage diversification through Suzuki-Miyaura or Buchwald-Hartwig cross-coupling, and the Boc protection permits selective deprotection after all side-chain modifications. This pathway underpins custom synthesis of tool compounds subject to project-specific, traceable batch history and full analytical documentation, which is mandatory in regulated research contracts and institutional collaborations.

    Industry compliance standards

    • OECD Good Laboratory Practice (GLP) for nonclinical safety studies
    • ISO/IEC 17025 accreditation for laboratory testing
    • ALCOA+ principles for data integrity in research batch records
    • REACH registration for exported research chemicals

    Typical usage ratio

    • Usually dosed at 0.9–1.0 equivalents in coupling steps to maximize yield with minimal byproduct formation. Quantity tailored per batch size and specific probe architecture.

    Downstream process integration

    • Initial use in protected indoline scaffold assembly.
    • Functional group diversification via cross-coupling with tailored aryl or alkyl units.
    • Final deprotection and purification performed prior to bioactivity evaluation.
    • Analytical QC to confirm finished probe structure and purity to specification.

    Final product types

    • Chemical probes for target validation assays
    • Small molecule tool compounds for pharmaceutical screening
    • Bioactive reference standards for preclinical studies
    • Scaffold-based libraries for high-content screening
    Free Quote

    Competitive N-Tert-Butoxycarbonyl-7-Bromoindoline prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: admin@sinochem-nanjing.com

    Get Free Quote of Sinochem Nanjing Corporation

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    N-Tert-Butoxycarbonyl-7-Bromoindoline: Expanding Possibilities in Synthesis

    Introducing the Compound

    N-Tert-Butoxycarbonyl-7-Bromoindoline, often known simply as Boc-7-bromoindoline, stands out in the toolbox of organic chemistry. This compound serves as a specialized building block, playing a unique role in applications that require selective indoline derivatization. Since the world of fine chemical synthesis depends so much on both purity and versatility, Boc-7-bromoindoline deserves attention for its mix of stable protection and reactive design.

    Structural Advantages and Specifications

    The molecule brings together two powerful features: the indoline framework, known for its stability and pi-rich aromaticity, and the tert-butoxycarbonyl (Boc) protecting group at the nitrogen. With a bromo substituent at the 7-position, this structure enables targeted transformations that chemists rarely find elsewhere. Its chemical formula, C13H16BrNO2, and a molar mass near 298.18 g/mol, point to a robust intermediate that balances bulk with reactivity. In a practical sense, the Boc group shields the indoline nitrogen during demanding conditions, letting reactions target other parts of the molecule. This selective protection means fewer unwanted byproducts and less time spent chasing down purification issues.

    If you’ve ever dealt with deprotection headaches or tried to fine-tune reaction pathways with more basic indoline variants, you already know the struggle of maintaining both reactivity and control. The Boc group resists both acidic and neutral conditions but surrenders quickly to mild acid, simplifying downstream work. Many labs appreciate that approach: get through your synthetic marathon, then trim off the Boc group right at the finish line with minimal fuss.

    Why the 7-Bromo Position Matters

    The story picks up intensity with the bromo atom. A bromine at the 7-position opens doors for Suzuki, Heck, or Buchwald-Hartwig coupling. In real-world terms, that means a chemist can tack on aromatic groups, amines, or heterocycles with crisp precision. Each swap creates a distinctive compound, which matters in drug discovery or material science. At the bench, being able to direct substitution specifically to the 7-position reduces the guesswork and the tedium of regioisomer separation.

    Compare this to unsubstituted indolines, which rarely offer the same breadth for customization. If you care about building variety, whether you’re in the middle of a medicinal library search or tailoring ligands for catalysis, this specific bromo-indoline hybrid is a less-traveled but highly rewarding path.

    Applications and Unique Benefits in Synthesis

    Painstaking work goes into constructing small-molecule probes, pharmaceutical intermediates, and novel catalysts. Having Boc-7-bromoindoline in the toolkit adds efficiency at several steps. Protected indolines like this one let researchers step through multi-stage syntheses without backtracking. By blocking the nitrogen, the compound withstands strong bases or oxidants, meaning multi-functional sequences stay on track. After the heavy-lifting is over, removing the Boc group re-exposes the indoline nitrogen for further chemistry.

    From my perspective, the difference shows up clearly during medicinal chemistry campaigns. Screening programs often run dozens of small modifications off a core scaffold. Boc-7-bromoindoline allows for rapid, parallel functionalization, shrinking the time it takes to iterate on lead compounds. The fact that the bromo substituent enables cross-couplings—one of the most widely used reactions in modern organic synthesis—lowers barriers for scalable route development. You end up spending more time focusing on structure-activity relationships, less rerunning separations or dealing with unstable intermediates.

    Comparison to Other Indoline Derivatives

    It’s easy to think any indoline will suffice, but the details prove otherwise. Simple indoline lacks both the tunability of selective halogenation and the security of nitrogen protection. Unprotected indoline derivatives attract side reactions, especially under basic or oxidative conditions. The Boc group not only manages this risk but also brings logistical advantages: longer shelf-life, lower tendency toward polymerization, improved handling—especially when stored over months or years.

    As for halogen position, alternatives like 5-bromo or 4-bromo indolines shift the reactivity map considerably. The 7-position, though less mainstream, slots into settings where other isomers cannot reach. The directionality affects both electronic and steric features of the indoline. In certain natural product syntheses or proprietary functional molecules, this detail can make or break the entire route. A comparison with N-acetyl or N-methyl indolines underscores a larger point: Boc protection removes with milder conditions, freeing synthesis from harsh acids or tricky decomposition. Fewer side reactions, less degradation, and better compatibility with fragile functional groups all add up.

    Experience from the Bench

    Working with protected indoline derivatives comes with its own rhythm. I remember joining a team focused on CNS-active scaffolds. We often started with Boc-7-bromoindoline because it handled library synthesis rounds with grace. Others on the team shared the same assessment—when you’re in the thick of sequential reactions, not worrying about competitive nitrogen alkylation lets planning stay clear-eyed. The Boc group’s removal—using TFA or even milder acids—felt almost ceremonial, often because we’d gotten through the tightrope-walk of cross-coupling and needed perfect conditions for the next stage.

    The ability to store this intermediate for extended periods gave us breathing room between experiment runs. Unlike some less stable indoline derivatives, which could yellow or degrade on the shelf, this compound remained stubbornly unchanged. It’s a quiet benefit but a real asset for any workflow facing delays, interruptions, or scale-up transitions.

    Key Usage: Enabling Clean Functionalization

    The real-world impact of Boc-7-bromoindoline comes from its reliability through purification and transformation. Beyond cross-coupling, the 7-bromo handle allows for rapid attachment of alkenes, aryls, or even alkynes. Several peer-reviewed studies cite its role in the shortest syntheses of meroterpenoids, tryptamine analogues, or fluorescence probes. Its consistent rate of reaction, both in small test batches and larger pilots, means tech transfer and reproducibility take fewer troubleshooting loops.

    The metabolic stability provided by Boc protection also matters. Some groups have shown that intermediates protected by Boc withstand metabolic simulation protocols more gracefully than those using acetyl, carbamate, or phosphate groups. While this doesn’t translate directly to in vivo stability, it does indicate smoother development for compounds facing preclinical validation.

    Supporting Quality and Traceability

    In an era where reproducibility stands front and center, the transparent characterization offered on Boc-7-bromoindoline matters. NMR, MS, and HPLC traces available from reputable suppliers ensure what arrives matches the spec. Lots tend to be accompanied by spectral libraries, making cross-checking straightforward. Spotting the correct Boc stretching frequencies and bromo-aryl signals gives confidence during both routine and analytical work. While this may seem a dry technical detail, it’s one that kept our team’s projects from running off track on more than one occasion.

    Keeping things on a human level, knowing a batch comes from an auditable supply chain—rather than a questionable source—means your research time goes further. Universities and smaller start-ups often have to stretch tight budgets; having reliable Boc-7-bromoindoline in stock kept us from wasting both reagents and effort.

    Environmental and Safety Considerations

    Like many bromo-organics, Boc-7-bromoindoline calls for thoughtful handling. Despite its stability, reactions involving strong acids or bases demand protective gear and adequate ventilation. Spills clean up with common lab absorbents, and safe disposal routes keep bromine content away from municipal systems. I always appreciated that fewer side reactions during synthesis translated to less solvent waste, less need for evaporative concentration, and fewer column purifications. The combination of stability and selective protection, in my experience, lines up with greener chemistry by reducing resource consumption.

    Sourcing the compound from suppliers adhering to environmental stewardship—those using renewable feedstocks or capturing process emissions—pushes labs further toward responsible practice. While no synthetic route proves entirely benign, clarity in bottle labeling, batch traceability, and consistent physical parameters steer labs away from avoidable hazards.

    Future Pathways in Research

    The next few years could see broader utility for this protected indoline. Growing interest in site-specific bioconjugation and molecular imaging often means looking for intermediates that play nice with biological substrates. The stability of Boc-protected indoline, combined with selective reactivity at the bromo position, suggests emerging opportunities in late-stage functionalization—especially for peptide-drug conjugates, fluorophore labeling, or targeted probes.

    Synthetic methods that work at low temperatures or with minimal excess reagents rely heavily on predictably protected building blocks. Boc-7-bromoindoline supports this need. Newer catalysis platforms, including nickel- or copper-catalyzed couplings, keep finding creative ways to coax value out of this structure. The cost and labor savings speak for themselves; each successful use trims weeks from development timelines and brings novel compounds to testing phases sooner.

    Any discussion of the future has to address scale. The shift toward batch-to-flow chemistry highlights intermediates that won’t clog columns, precipitate in tubes, or break down under mild heat. This compound, in the runs I’ve seen, adapts seamlessly to microscale and gram-scale syntheses, further cementing its place in today’s high-throughput labs.

    Improving Access and Reducing Barriers

    Despite its utility, one persistent challenge involves access in educational and small-scale environments. Regional supply chain disruptions, tight customs protocols for bromo-substituted organics, and limited on-campus stocking all raise the barrier for underfunded labs. Greater sharing of safe handling guidelines and more community-driven protocols could help close this gap. Online repositories, open-access journals, and collaborative consortia—where researchers upload their synthetic routes and safety notes—make it easier for students and new researchers to work confidently with Boc-7-bromoindoline.

    Supplier initiatives focused on smaller, researcher-friendly aliquots, improved hazard labeling, or “starter kits” for less experienced users also lower the learning curve. I remember guiding undergraduates through their first manipulations of this compound, and with step-by-step protocols, the anxiety faded away. The more approachable the product, the broader its adoption, and the wider the field of discoveries it enables.

    Potential Solutions for Synthesis Bottlenecks

    Every synthetic chemist stares down bottlenecks sooner or later: protection group mismatches, purification nightmares, or sluggish reactions. Boc-7-bromoindoline doesn’t solve every problem, but it does address a handful of key pain points. Its thermal stability, single-step deprotection, and broad cross-coupling compatibility eliminate hours of troubleshooting. Applying slightly acidic conditions restores the free indoline while avoiding side reactions that plague more delicate intermediates.

    On the scale-up side, clear solubility in common organic solvents—dichloromethane, ethyl acetate, or acetonitrile—means less trial and error for solution-phase synthesis. The compound’s clean chromatographic profile (as seen in routine HPLC runs) saves money on costly silica and reduces run times. Most high-yield transformations published with Boc-7-bromoindoline report minimal need for extensive purification, a marked improvement over unprotected indolines or di-substituted variants.

    Bridging Industry and Academic Research

    The divide between industry and academia often feels like an impassable gulf, with academic teams chasing novelty while industry focuses on efficiency and throughput. Boc-7-bromoindoline forms a bridge between these worlds. The robust protection and versatile bromo functionality fit both exploratory research and GMP pathway validation. This shared ground means more cross-pollination of ideas, with academic discoveries reaching market faster and industrial workflows borrowing innovations first tested in university settings.

    Anecdotes from colleagues who switched careers bear this out: projects that once felt limited by clunky intermediates or multi-day purifications now move forward at a faster clip. With better access to protected and pre-functionalized indolines, a greater diversity of medicinal chemists, materials scientists, and chemical biologists can collaborate fruitfully. This compound doesn’t just support chemistry; it nudges the research ecosystem toward speedier, more reliable results.

    Navigating Intellectual Property and Open Science

    Many modern research programs grapple with patent thickets around scaffold modifications and protection strategies. Boc-7-bromoindoline, owing to its clean modular structure, helps sidestep some of the complexity. Unlike protected indolines burdened by overlapping claims or proprietary production, this variant shows up in both publicly funded and commercial research, enabling broader innovation without overhanging restrictions.

    Sharing results openly, particularly negative ones, invigorates discovery. Publishing both successful routes and failed attempts using Boc-7-bromoindoline builds a more honest map of its capabilities. As labs publish comparative yields, telescoped (one-pot) methodologies, and compatibility with novel reagents, everyone benefits from richer collective knowledge. In my own experience, open communication—at conferences or through preprint archives— closes the gap between expectation and practice, reducing wasted cycles and driving more creative deployment of this tool.

    Connecting with the Next Generation of Chemists

    Students entering organic synthesis today stand on the shoulders of decades of optimization. Boc-7-bromoindoline forms an ideal teaching example to illustrate the interplay between protection, reactivity, and selectivity. A guided project from bromoindoline derivatization through deprotection, cross-coupling, and final product isolation lets students build confidence and technical savvy. Watching their skills grow as they master air-free techniques, develop new purification strategies, and interpret spectra highlights both the versatility and reliability of this compound.

    Hand-on experience with modern intermediates frames the real challenges facing researchers and forges the resilience demanded in innovation-driven environments. As an educator or mentor, seeing students transition from hesitant pipetting to bold experiment design reminds me that reliable, well-characterized compounds like Boc-7-bromoindoline shape not just individual research outcomes, but the careers of the next wave of chemists.

    Closing Thoughts: The Compound as a Catalyst for Progress

    Looking across a career spent with diverse protection strategies, lab environments, and project goals, I see N-Tert-Butoxycarbonyl-7-Bromoindoline as more than a chemical—it’s a catalyst for progress. Its skillful protection, smart reactivity, and trustworthy purity set the stage for both creative breakthroughs and day-to-day dependability. Whether it’s helping an industrial team meet production targets or powering a student’s first successful coupling reaction, this indoline derivative earns its reputation not by flash, but by steady results.

    For labs striving to speed up cycles, secure better outcomes, and keep science moving forward, leveraging proven, thoughtfully designed intermediates moves the work from theoretical ambition to published discovery. Boc-7-bromoindoline gives researchers the control, reliability, and creativity required for both ambitious projects and the routine synthesis that underpins our field. In chemistry, as in life, trusted foundations make all the difference.